Computational modelling prediction and clinical validation of impact of benralizumab on airway smooth muscle mass in asthma

Eur Respir J. 2019 Nov 14;54(5):1900930. doi: 10.1183/13993003.00930-2019. Print 2019 Nov.
No abstract available

Publication types

  • Letter

MeSH terms

  • Anti-Asthmatic Agents / pharmacology*
  • Anti-Asthmatic Agents / therapeutic use
  • Antibodies, Monoclonal, Humanized / pharmacology*
  • Antibodies, Monoclonal, Humanized / therapeutic use
  • Asthma / drug therapy
  • Asthma / pathology*
  • Bronchi / drug effects*
  • Bronchi / pathology*
  • Computer Simulation*
  • Forecasting
  • Humans
  • Muscle, Smooth / drug effects*
  • Muscle, Smooth / pathology*
  • Organ Size

Substances

  • Anti-Asthmatic Agents
  • Antibodies, Monoclonal, Humanized
  • benralizumab

Associated data

  • ClinicalTrials.gov/NCT00659659